Repurposing SGLT-2 Inhibitors to Target Aging: Available Evidence and Molecular Mechanisms
Article
[키워드] accompanied
activity
addition
aging
all-cause mortality
animal model
animal models
available data
benefit
Biomarker
blunt
caloric restriction
calories
cardiovascular diseases
Cardiovascular outcomes
cellular senescence
clinical study
clinical trials
Compound
COVID-19
decrease
diabetes
driver
drug
drugs
employment
Evidence
Fatty acid
feature
Glucose
heart failure
humans
IL-6
independent
inflammaging
Inflammasome
inhibitor
inhibitors
intrinsic
Kidney disease
low-grade inflammation
Meta-analysis
modulating
modulation
molecular
Mortality
nutrient-sensing pathways
observational studies
outcomes
pathway
Patient
promote
provided
repurposing
selected
senescence
sodium-glucose cotransporter 2 inhibitors.
substrates
suggested
Support
systemic effects
systemic level
target
Urine
[DOI] 10.3390/ijms232012325 PMC 바로가기
[DOI] 10.3390/ijms232012325 PMC 바로가기